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Keratinocytes have histamine H1 and H2 receptors,
but their functions are poorly understood. To clarify
the role of histamine receptors in the epidermis, we
examined the effects of histamine receptor antago-
nists and agonists applied epicutaneously on the
recovery of skin barrier function disrupted by tape
stripping in hairless mice. Histamine H2 receptor
antagonists famotidine and cimetidine accelerated
the recovery of skin barrier function, but histamine
and histamine H2 receptor agonist dimaprit delayed
the barrier repair. Application of compound 48/80, a
histamine releaser, also delayed the recovery.
Imidazole, an analog of histamine, had no effect.
The histamine H1 receptor antagonists diphenhydra-
mine and tripelennamine accelerated the recovery.
Histamine H3 receptor agonist N
a-methylhistamine
and antagonist thioperamide had no effect. In addi-
tion, topical application of famotidine or diphenhy-
dramine prevented epidermal hyperplasia in mice
with skin barrier disrupted by acetone treatment in a
dry environment (humidity < 10%) for 4 d. In con-
clusion, both the histamine H1 and H2 receptors in
the epidermis are involved in skin barrier function
and the cutaneous condition of epidermal hyperpla-
sia. Key words: diphenhydramine/famotidine/itch/low
humidity. J Invest Dermatol 116:261±265, 2001
H
istamine is well known as a chemical mediator that
plays important roles in allergic in¯ammatory and
immune reactions (Falus and Meretey, 1992). In
skin, it is synthesized and stored in mast cells in the
dermis but is also generated in keratinocytes
(Malaviya et al, 1996). Histamine in the epidermis is derived from
the keratinocyte itself and from mast cells in the dermis, but the role
of histamine in the epidermis is still largely unknown. Histamine
has three types of receptors. In skin, both the histamine H1 receptor
and histamine H2 receptor exist (Greaves and Davies, 1982). The
histamine H1 receptor is considered to contribute to itch, and
histamine H1 receptor antagonists are clinically used for pruritus in
patients with atopic dermatitis (Zuberbier and Henz, 1999).
Keratinocytes have histamine H2 receptors, but their function is
not clearly understood (Fitzsimons et al, 1998). The Ca2+
concentration affects the quantity of histamine H2 receptors on
keratinocytes as well as the differentiation of keratinocytes
(Fitzsimons et al, 1999). The histamine H2 receptor also accelerates
cell proliferation (Wang et al, 1997) and affects the immune system
(Nielsen and Hammer, 1992). Attempts to assess the clinical
ef®cacy of histamine H2 receptor antagonists on psoriasis have not
been successful (Nielsen, 1996). The existence and the role of the
histamine H3 receptor in skin are still unclear in humans (Kavanagh
et al, 1998). In rats, however, the histamine H3 receptor is involved
in the autoregulation of histamine release on mast cells (Ohkubo
et al, 1994), and the regulation of substance P release is also
mediated via prejunctional histamine H3 receptors located on
peripheral endings of sensory nerves (Ohkubo et al, 1995).
It is well known that seasonal changes affect the condition of
normal skin and in¯ammatory dermatoses. The low humidity
during winter makes the skin condition worse (Wilkinson and
Rycroft, 1992; Sauer and Hall, 1996), and it sometimes causes itch.
Low humidity also stimulates epidermal DNA synthesis (Sato et al,
1998), and ampli®es the hyperproliferative response to disruption of
skin barrier function (Denda et al, 1998). The skin barrier function
is the epidermal permeability barrier mechanism at the level of the
stratum corneum, which allows life in a terrestrial dry environment.
Acute barrier disruption by tape stripping elicits a homeostatic
repair response in the epidermis. Substances that accelerate the
recovery of the disrupted skin barrier have been reported to be
effective against epidermal hyperplasia (Denda et al, 1997).
In this study, we examined whether histamine H1 and H2
receptor antagonists accelerate the recovery of disrupted skin
barrier function and are effective against epidermal hyperplasia.
MATERIALS AND METHODS
Animals Hairless mice, 7±10 wk old (HR-1, Hoshino, Japan) were used.
Before the experiment, animals were caged separately for at least 4 d. These
cages were maintained in a room kept at 22°C±26°C with a relative
humidity of 40%-70%. All experiments were approved by the Animal
Research Committee of the Shiseido Research Center in accordance with
the National Research Council (NRC) Guide (National Research
Council, 1996).
Compounds Famotidine, cimetidine, diphenhydramine hydrochloride,
tripelennamine hydrochloride, histamine dihydrochloride, imidazole,
compound 48/80, and polyethylene glycol (MW 300) were purchased
from Sigma (St. Louis, MO). Na-methylhistamine dihydrochloride,
thioperamide maleate, and dimaprit dihydrochloride were purchased
from RBI (Natick, MA). The test compound was dissolved or suspended
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in the control vehicle, which was a mixture of polyethylene
glycol:ethanol:distilled water 1:3:1 in order to increase the solubility of
the compounds, which have different polarities. These test samples were
used at a concentration of 5%, which was determined in a preliminary
study, except for histamine, which was used at 0.1%, its pharmacologic
concentration for histamine-induced itch. The pH was measured with a pH
test paper (Toyo Roshi, Tokyo). The pH of each test sample was adjusted
below 6.0 with HCl, because recovery of skin barrier function is impeded
at a neutral pH (Mauro et al, 1998a).
Recovery of barrier function Barrier disruption was achieved by
repeated applications of cellophane tape (Scotch Crystal Clear Tape, 3M,
St. Paul, MN) on mouse ¯ank skin. The procedure was terminated when
transepidermal water loss (TEWL) levels reached 8.5 6 1.5 mg per cm2
per h. Normal TEWL is less than 0.3 mg per cm2 per h. TEWL was
measured by using an electrolytic water analyzer (Meeco, Warrington, PA).
We disrupted the skin on both ¯anks of mice. Immediately after barrier
disruption 100 ml of test sample was applied on one side, and medium was
applied on the other side as a control. TEWL was measured before barrier
disruption, immediately after barrier disruption, and at 3 h, 6 h, and 9 h after
barrier disruption. The time points of the measurement were determined in
a preliminary examination to be appropriate for the detection of the effect
of the test compound. The barrier recovery results are expressed as
percentage recovery because of variations from day to day in the extent of
barrier disruption. In each animal the percentage recovery was calculated
using the following formula: [1 - (TEWL at indicated time ± baseline
TEWL)/(TEWL immediately after treatment ± baseline TEWL)] 3 100%.
All data were compared with data from simultaneously studied controls. To
avoid scratching during the observation, we ®xed the hind legs of the
animal with ¯exible tape.
Low-humidity condition Animals were kept separately in 7.2 l cages in
which the relative humidity was maintained at less than 10% with dry air.
The temperature was the same in all cages (22°C±26°C), and fresh air was
circulated 100 times per hour. Animals were kept out of the direct stream
of air. The animal's behavior was not restricted during the experiments.
The weight gain and food intake of animals kept in a dry condition was not
different from that of those kept in a normal condition during the course of
the study. The level of NH3 was always below 1 ppm.
Epidermal hyperplasia with barrier disruption and exposure to a
dry atmosphere We applied 100 ml of test sample per 6 cm2 of ¯ank skin
of mouse, and applied medium on the other side as a control. We kept the
aminals in a dry condition for 48 h before barrier disruption. The test
sample was applied from the onset of the experiment, because the dry
condition itself without barrier disruption also induces epidermal
proliferation and hyperplasia (Sato et al, 1998). Then, the area of the
¯ank skin was treated with acetone-soaked cotton balls, as described
previously (Denda et al, 1998). The procedure was terminated when
TEWL reached 1.2±1.8 mg per cm2 per h. Immediately after barrier
disruption 100 ml of a 5% test sample was applied again to the treated area,
and the animals were kept in a dry condition for 48 h. At the end of the
experiment, the animals were killed and the skin from the treated versus
control ¯anks was removed. After ®xation with 4% paraformaldehyde, full-
thickness skin samples were embedded in paraf®n, sectioned (4 mm), and
processed for hematoxylin and eosin staining. On each section, 50 areas
were selected at random; the thickness of the epidermis was measured with
an optical meter, and the mean value was calculated. Measurements were
carried out in an observer-blinded fashion. The results are represented as a
proliferative percentage to intact skin.
Statistics Data are presented as mean 6 SD. Statistical differences were
determined by ANOVA and Fisher's protected least signi®cant difference as
post hoc test.
RESULTS
We ®rst evaluated the effects of the antagonists of the three types of
histamine receptor on barrier recovery. As shown in Fig 1, the
histamine H1 receptor antagonist diphenhydramine signi®cantly
accelerated barrier recovery after tape stripping (Fig 1A, 41% and
21% faster at 3 h and 6 h, respectively), and the H2 receptor
antagonist famotidine also accelerated barrier repair signi®cantly
(Fig 1B, 78%, 26%, and 12% faster at 3 h, 6 h, and 9 h,
respectively). On the other hand, the histamine H3 receptor
antagonist thioperamide did not affect the barrier repair process
(Fig 1C). Additionally, we con®rmed that the other histamine H1
and H2 receptor antagonists had similar effects on the barrier
recovery (Table I). The histamine H1 receptor antagonist tripe-
lennamine signi®cantly accelerated barrier recovery after tape
stripping (204% faster at 3 h), and the H2 receptor antagonist
cimetidine also accelerated barrier repair signi®cantly (12-fold and
119% faster at 3 h and 6 h, respectively).
We next evaluated the effects of the histamine receptor agonists,
histamine releaser, and histamine analog. As shown in Fig 2,
histamine itself delayed the barrier repair process signi®cantly
(Fig 2A, 28% slower at 9 h), and the histamine H2 receptor agonist
dimaprit also delayed barrier recovery signi®cantly (Fig 2B, 20%
slower at 6 h). Furthermore, the histamine releaser compound
48/80 delayed the barrier repair process signi®cantly (Fig 2C, 12%
slower at 6 h). On the other hand, the histamine H3 receptor
agonist Na-methylhistamine and histamine analog imidazole did
not affect the barrier repair process (Table I). Scratching behavior
was not observed during the experiments.
Finally, we tested whether histamine H1 and H2 receptor
antagonists also have an effect on skin disorders in vivo. To quantify
the effect of histamine receptor antagonists, we measured the
epidermal thickness after barrier disruption with acetone in animals
kept in a dry condition. As shown in Fig 3, famotidine signi®cantly
inhibited epidermal hyperplasia compared with the control, dose-
dependently. The inhibition of epidermal hyperplasia by 1% and
5% famotidine was 43% and 78%, respectively. Also, 5%
diphenhydramine inhibited it signi®cantly (83%).
DISCUSSION
The results of this study suggest that both the histamine H1 and
histamine H2 receptors contribute to the maintenance of skin
barrier function. We also found that both types of histamine
receptor antagonist inhibited epidermal hyperplasia with barrier
disruption induced by acetone treatment in mice kept in a dry
condition. Therefore, the histamine H1 and H2 receptors may
Figure 1. Histamine H1 and H2 receptor an-
tagonists accelerate barrier recovery in
mouse skin after tape stripping. Histamine H3
receptor antagonist has no effect. The ¯ank skin
was treated until TEWL reached 8.5 6 1.5 mg
per cm2 per h. Immediately after barrier disruption
100 ml of 5% diphenhydramine (A), 5% famotidine
(B), 5% thioperamide (C), or control vehicle
(polyethylene glycol:ethanol:distilled water 1:3:1)
was applied to the treated area. TEWL was mea-
sured at the times indicated after barrier disrup-
tion. Data are presented as mean 6 SD (n = 4).
*p < 0.05, **p < 0.01, ***p < 0.001; p-values
were calculated by ANOVA and Fisher's pro-
tected least signi®cant difference as post hoc test.
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contribute not only to skin barrier function but also to epidermal
proliferation or in¯ammation. Moy et al (2000) reported that
histamine altered vascular endothelial barrier function at cell-cell
and cell-matrix sites, but the effects of histamine and histamine
receptor antagonists on the epidermal barrier function were not
reported. The mechanism of the ef®cacy of histamine H1 and H2
receptor antagonists on skin barrier function and skin condition also
has not been elucidated.
Macroscopically, mast cell degranulation increases in a dry
condition after acetone treatment (Denda et al, 1998). Histamine
synthesis is also induced by ultraviolet (UV) B in keratinocytes
(Malaviya et al, 1996). These ®ndings imply that the histamine
content in skin tissue increases during cutaneous in¯ammation. UV
radiation enhances histamine sensitivity in keratinocytes, and
prostaglandin synthesis in keratinocytes after UV radiation is
mediated by histamine (Pentland et al, 1990). Histamine also
enhances UVB-induced interleukin-6 (IL-6) production in kera-
tinocytes (Shinoda et al, 1998). IL-6 is a proin¯ammatory cytokine,
which may be responsible for mast cell differentiation and
keratinocyte proliferation (Saito et al, 1996). Histamine accelerates
cell proliferation (Wang et al, 1997) and IL-6 also accelerates it
(Grossman et al, 1989). These reports suggest that histamine may
regulate skin conditions. Although the results of many trials for oral
application of histamine H2 receptor antagonists to psoriasis with
epidermal hyperplasia were not consistent, this study showed that
epicutaneous application of histamine H2 receptor antagonists may
inhibit keratinocyte proliferation and accelerate barrier formation.
Further study is needed to elucidate the function of histamine H2
receptor in the epidermis.
We consider that itch may be one of the important factors that
exacerbate the skin condition because scratching behavior results in
disruption of skin barrier function. In our study, scratching was
prevented during the barrier repair process. Thus, the effects of
histamine H1 and H2 receptor antagonists were due to biochemical
effects on the barrier homeostasis. Histamine H1 receptor
antagonists are used for the treatment of pruritus in patients with
atopic dermatitis (Zuberbier and Henz, 1999). In addition, the
histamine H2 receptor antagonist inhibits the scratching behavior
induced by histamine and compound 48/80 in mice (Inagaki et al,
1999). Therefore, the histamine H2 receptor antagonist in
combination with histamine H1 receptor antagonist may not only
accelerate barrier repair but also inhibit scratching behavior, which
breaks the skin barrier. Schmelz et al (1997) reported that the
microneurographic pattern of the response to histamine of
histamine-sensitive c-®ber, which was mechanically insensitive,
matched the time course of the itch sensation in the cutaneous
branch of the peroneal nerve in humans. This type of c-®ber,
which has very large innervation territories in skin, probably
represents the afferent units long searched for mediating itch
sensations (Schmelz et al, 1997). Further study is necessary to
elucidate the various roles of histamine and the mechanism in skin
including histamine H3 receptors on mast cells and on peripheral
endings of sensory nerves that may regulate substance P release
(Ohkubo et al, 1995).
In this study we demonstrated that epicutaneous application of
histamine H1 and H2 receptor antagonists accelerated the recovery
of skin barrier function disrupted by tape stripping, and it also
inhibited the epidermal hyperplasia with barrier dysfunction
induced by acetone treatment in mice kept in a dry condition.
Histamine and histamine receptor antagonists have effects on
proliferation, differentiation, cytokine production and its release,
and ion channels. The effects of histamine receptor antagonists via
Table I. Effects of other histamine-related compounds on skin barrier recovery disrupted by tape stripping in miceb
Recovery %b
3 h 6 h 9 h
histamine H1 receptor antagonist
tripelennamine control 18.5 6 20.3 46.5 6 23.5 50.7 6 28.7
treatment 56.3 6 12.4** 60.2 6 14.3 66.0 6 19.0
histamine H2 receptor antagonist
cimetidine control 2.39 6 10.8 23.4 6 17.2 31.1 6 12.9
treatment 28.0 6 17.2* 51.3 6 26.5* 51.5 6 12.3
histamine H3 receptor agonist
Na-methylhistamine control 48.1 6 6.9 76.4 6 5.7 88.4 6 1.9
treatment 43.5 6 10.3 80.0 6 1.7 87.5 6 4.7
histamine analog
imidazole control 4.56 6 15.1 39.7 6 12.4 50.0 6 14.4
treatment 9.28 6 18.0 28.7 6 11.7 41.9 6 14.5
aRecovery rate was measured as described in the Materials and Methods.
bData are presented as mean 6 SD (n = 4.8). *p< 0.05, **p< 0.01, p values were calculated by ANOVA and Fisher's protected least signi®cant difference (Fisher's PLSD) as
post hoc test.
Figure 2. Histamine, histamine H2 receptor
agonist, and histamine releaser delay barrier
recovery in mouse skin after tape stripping.
The ¯ank skin was treated until TEWL reached
8.5 6 1.5 mg per cm2 per h. Immediately after bar-
rier disruption 100 ml of 0.1% histamine (A), 5%
dimaprit (B), 5% compound 48/80 (C,) or control
vehicle (polyethylene glycol:ethanol:distilled water
1:3:1) was applied to the treated area. TEWL was
measured at the times indicated after barrier dis-
ruption. Data are presented as mean 6 SD (n = 4).
*p < 0.05,**p < 0.01; p-values were calculated by
ANOVA and Fisher's protected least signi®cant
difference as post hoc test.
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histamine H1 or H2 receptor on them have been reported for
various tissues. Histamine-induced DNA synthesis is inhibited by
H1 receptor antagonists in carcinoma and melanoma cells that
express histamine H1 receptor (Tilly et al, 1990). Pyrilamine, a
histamine H1 receptor antagonist, blocks histamine-mediated
UVB-induced IL-6 production in human keratinocytes (Shinoda
et al, 1998). Histamine H1 receptor antagonists block cardiac Na+,
Ca2+, and K+ channels (Delpon et al, 1999). On the other hand,
cimetidine, a histamine H2 receptor antagonist, reverses histamine-
mediated increase in IL-1a-induced IL-1b synthesis in peripheral
blood mononuclear cells (Vannier and Dinarello, 1993). Histamine
suppresses IL-12 and stimulates IL-10 production in peripheral
monocytes, and cimetidine antagonizes these effects (Elenkov et al,
1998). H2 receptor antagonists reverse histamine-induced increase
of IL-4, IL-5, and interferon-g production in T cells (Krouwels et al,
1998). Cimetidine inhibits cell proliferation and c-fos gene
transcription induced by histamine H2 receptor activation in
human embryonic kidney cells stably transfected with human H2
receptor (Wang et al, 1997). Histamine and the selective histamine
H2 receptor agonist dimaprit reduced a speci®c K+ current in
myenteric neurons from guinea pig small intestine, and cimetidine
suppressed it (Starodub et al, 2000). But, the roles of each type of
histamine receptor in the epidermis are unknown, and the
mechanism of barrier repair acceleration of histamine H1 and H2
receptor antagonists is also still unknown. The production of
various kinds of cytokines like IL-1a and tumor necrosis factor a in
keratinocytes increases after skin barrier disruption (Wood et al,
1992; Nickoloff and Naidu, 1994) and not only the production of
epidermal IL-1a but also its release increases after skin barrier
disruption (Wood et al, 1996). Therefore, the histamine H1 and H2
receptors may regulate skin conditions via these cytokines. Also the
quantity of histamine receptor on keratinocytes may change with
the skin condition. In this study the effects of histamine H1 and H2
receptor antagonists appear so early that they may be involved in
the secretion of lamellar bodies, which are related to the epidermal
calcium and potassium gradient (Lee et al, 1992; Menon et al, 1994).
Mauro et al (1998b) showed an alteration of calcium and potassium
localization immediately after barrier disruption. Topical applica-
tion of calcium or potassium delayed the barrier recovery (Lee et al,
1992). Keratinocyte K+ channels mediate Ca2+-induced differ-
entiation (Mauro et al, 1997). These reports suggest that calcium
and potassium concentration in the epidermis strongly relates to
epidermal barrier homeostasis. On the other hand, Koizumi and
Ohkawara (1999) demonstrated that histamine H2 receptor
antagonist cimetidine speci®cally inhibited histamine-mediated
increase in intracellular Ca2+ of cultured human keratinocytes
signi®cantly, although histamine H1 receptor antagonist diphenhy-
dramine did not inhibit it signi®cantly. Moreover, some potassium
currents are regulated by histamine H2 receptor (Yazawa and
Abiko, 1993; Adeagbo and Oriowo, 1998; Starodub et al, 2000).
Fitzsimons et al (1999) reported that the quantity of histamine H2
receptors changes with Ca2+ concentration in relation to
differentiation in epidermal tumor cell lines. These reports also
suggest that the differences in the function of histamine H1 and H2
receptors in the epidermis may depend on the regulation of calcium
and potassium concentration in the epidermis. The roles of each
histamine receptor in calcium and potassium concentration and ion
transport including ion channels in the epidermis remain to be
investigated. Furthermore, Lichey et al (1994) reported that
histamine release is modulated by glycosphingolipids in basophils.
But, the relationship between histamine receptors and lipid
synthesis has not been clari®ed yet. A mechanistic study of the
relationship between histamine receptors and the homeostatis of
intercellular lipids in the stratum corneum should be carried out.
In conclusion, both the histamine H1 and histamine H2 receptors
in the epidermis are involved in skin barrier function and the skin
condition of epidermal hyperplasia.
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